← Back
$TVTX All transactions

Travere Therapeutics, Inc.

G 10b5-1 Plan

$ Value

$0

Shares

1,078

Price

$0

Filed

Nov 4

Insider

Name

Heerma Peter

Title

CHIEF COMMERCIAL OFFICER

CIK

0001789617

Roles

Officer

Transaction Details

Transaction Date

2025-11-03

Code

G

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

117,993

Footnotes

This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. | This transaction represents a charitable gift of 1,078 shares of common stock to a donor advised fund, which was gifted pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

Filing Info

Accession No.

0001789617-25-000007

Form Type

4

Issuer CIK

0001438533

Heerma Peter's History

Date Ticker Type Value
2026-04-13 TVTX A $0
2025-12-24 TVTX $199K
2025-11-03 TVTX G $0
2025-10-31 TVTX $196K
2025-10-28 TVTX $80K
2025-09-23 TVTX G $0
2025-05-05 TVTX $37K
2025-05-02 TVTX M
2025-05-02 TVTX M $0

Other Insiders at TVTX (90d)

Insider Bought Sold Last
LYONS GARY A $329K 2026-04-14
REED ELIZABETH E
Chief Legal Officer and GC
$2.1M 2026-04-15
REED ELIZABETH E / Heerma Peter / Inrig Jula
Chief Legal Officer and GC
$303K 2026-04-14
Baynes Roy D. $1.7M 2026-04-14
ROTE WILLIAM E.
Chief Research Officer
$356K 2026-04-22
Dube Eric M
CHIEF EXECUTIVE OFFICER
$4.5M 2026-04-15
Heerma Peter
CHIEF COMMERCIAL OFFICER
2026-04-13
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
$903K 2026-04-14
Inrig Jula
CHIEF MEDICAL OFFICER
$43K 2026-04-15
Cline Christopher R.
CHIEF FINANCIAL OFFICER
$349K 2026-04-15